Butylphthalide combined with donepezil for the treatment of vascular dementia: a meta-analysis,Journal of International Medical Research

当前位置： X-MOL 学术 › J. Int. Med. Res. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Butylphthalide combined with donepezil for the treatment of vascular dementia: a meta-analysis
Journal of International Medical Research ( IF 1.6 ) Pub Date : 2024-03-28 , DOI: 10.1177/03000605231223081
Puqing Liu ₁ , Xiangjuan Liu ₂ , Jingwen Chen ₃ , Yi Zhang ₄ , Jun Chen ₁ , Lei Yu ₅ , Zhangxuan Shou ₁

Affiliation

ObjectiveTo systematically evaluate the efficacy and safety of butylphthalide combined with donepezil versus butylphthalide monotherapy for the treatment of vascular dementia.MethodsRandomized controlled trials were searched in electronic databases, including PubMed, Embase, the Cochrane Library, China National Knowledge Infrastructure, Chinese Science and Technology Periodical Database (VIP), Wan Fang, and China Biology Medicine from inception to 29 November 2022. Two reviewers independently screened the papers and extracted data from the included studies. The data were processed using RevMan5.4 statistical software.ResultsNine randomized controlled trials (n = 1024) were included in this meta-analysis. Regarding the primary outcomes, compared with butylphthalide monotherapy, combined butylphthalide and donepezil treatment exhibited significantly greater total clinical efficacy (relative risk = 1.24, 95% confidence interval [1.17, 1.31]) and did not increase the adverse event rate (relative risk = 1.39, 95% confidence interval [0.91, 2.14]). Regarding the secondary outcomes, the meta-analysis results for the Mini-Mental State Examination, abilities of daily living, and Montreal Cognitive Assessment scores and the interleukin-6, tumor necrosis factor-α, and superoxide dismutase blood levels all supported combined butylphthalide and donepezil treatment.ConclusionButylphthalide combined with donepezil may be a better treatment strategy than donepezil alone for the treatment of vascular dementia in clinical practice.

更新日期：2024-03-28

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>